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University, Chengdu, ChinaABSTRACT Intramolecular chaperones (IMCs), which are specific domains/segments encoded in the primary structure of
proteins, exhibit chaperone-like activity against the aggregation of the other domains in the same molecule. In this research,
we found that the truncation of the linker greatly promoted the thermal aggregation of the isolated C-terminal domain (CTD)
of rabbit muscle creatine kinase (RMCK). Either the existence of the linker covalently linked to CTD or the supply of the synthetic
linker peptide additionally could successfully protect the CTD of RMCK against aggregation in a concentration-dependent
manner. Truncated fragments of the linker also behaved as a chaperone-like effect with lower efficiency, revealing the impor-
tance of its C-terminal half in the IMC function of the linker. The aggregation sites in the CTD of RMCK were identified by molec-
ular dynamics simulations. Mutational analysis of the three key hydrophobic residues resulted in opposing effects on the thermal
aggregation between the CTD with intact or partial linker, confirming the role of linker as a lid to protect the hydrophobic residues
against exposure to solvent. These observations suggested that the linkers in multidomain proteins could act as IMCs to
facilitate the correct folding of the aggregation-prone domains. Furthermore, the intactness of the IMC linker after proteolysis
modulates the production of off-pathway aggregates, which may be important to the onset of some diseases caused by the
toxic effects of aggregated proteolytic fragments.INTRODUCTIONStructure and stability are key factors that define the function,
regulation, and turnover of a protein. It is believed that the
information that governs the nascent polypeptide folding to
its native structure is encoded in the primary sequence of
a protein (1). Although many proteins have been character-
ized to be able to fold correctly in vitro, misfolding and
aggregation are frequently encountered in both laboratory
investigations and industrial production of many proteins
(2). The folding of multimeric/multidomain proteins are
particularly complex and are more prone to compete with
the unproductive off-pathway aggregation than the single
domain small proteins. Aberrant protein aggregation has
also been associated with many severe diseases including
neurodegenerative diseases (2) and familial conformational
diseases (3). Moreover, the in vivo folding of nascent poly-
peptides is strongly dependent on the particular environment
(2), such as macromolecular crowding (4). To achieve reli-
able and efficient folding of proteins for various functions,
the cells have evolved quality control systems to assist the
correct folding, to stabilize the native structure, and toSubmitted April 9, 2012, and accepted for publication July 3, 2012.
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0006-3495/12/08/0558/9 $2.00degrade the misfolded proteins. In particular, it is now well
established that factors facilitating protein folding include
folding catalysts, molecular chaperones, chemical chaper-
ones, and intramolecular chaperones (IMCs) (2,5,6).
Unlike the well-known molecular chaperones, the IMCs
are specific domains/segments encoded in the primary struc-
ture of proteins (6). IMCs were initially reported in 1987 (7),
and have been identified in many proteins. Most of the IMCs
were characterized in preproproteins, in which the prereg-
ions at the N- or C-terminus play a crucial role in the assis-
tance of correct folding or association of the functional
domains (6). These propeptides are usually removed from
the matured proteins after the completion of protein folding.
In addition to preproproteins, IMCs are also proposed to
exist in several other proteins (8–12), in which these
regions/domains are not cleaved and play a role in protein
functions. These observations strongly suggest that IMCs
may be widely distributed in proteins to control the hierar-
chical folding processes (13). However, this concept needs
to be further verified by investigations of more proteins
and of detailed mechanisms of IMCs.
Creatine kinase (CK, EC 2.7.3.2), a key enzyme involved
in the intracellular energetic homeostasis of vertebrate
excitable tissues that require large energy fluxes (14), cata-
lyzes the reversible transfer of the high-energy phosphate
between the ATP/ADP and creatine/phosphocreatine
systems. It has been well established that in vertebrate
cells, the intracellular microdomains associated with ATP
production and consumption are mainly connected by thehttp://dx.doi.org/10.1016/j.bpj.2012.07.002
Chaperone-Like Effect of the Linker of CK 559phosphocreatine-CK network (14). Due to its importance
in intracellular energetic homeostasis, the dysfunction or
deficiency of CK has been associated with many serious
diseases (15–18). In particular, CK aggregation has been
observed for an acute myocardial infarction patient with
inherited D54G mutation (16) and for cells subjected to
stress caused by nitrogen-based oxidants (19).
Each subunit of CK contains two domains, the N-terminal
domain (NTD) and the C-terminal domain (CTD) connected
by a long linker (Scheme 1). The small NTD contains only
a-helices and consists of ~100 residues, whereas the large
CTD contains ~250 residues folding into a core eight-
stranded antiparallel b-sheet surrounded by six helices. The
linker region has been shown to participate in themuscle-iso-
form-specific binding to the M-line (20). Recently, we found
that the CTD was more likely to be the binding site during
rabbit muscle CK (RMCK) aggregation (21) and the linker
plays a crucial role in RMCK folding (10,22). These findings
led to the hypothesis that the linker might act as an IMC to
stabilize CTD. However, the linker between domains is
rarely identified to be an IMC or to play a crucial role in
folding. To further investigate the role of the linker in CK
folding, the isolated CTD was overexpressed in Escherichia
coli, with either an intact or a truncated linker (Scheme 1).
The results herein strongly suggested that the intact linker
exhibited chaperone-like activity to facilitate the folding of
the aggregation-prone CTD.MATERIALS AND METHODS
Chemicals
Sodium dodecyl sulfate, ultrapure guanidine hydrochloride, Tris, ATP,
sequencing-class trypsin, and protease K were purchased from Sigma-SCHEME 1 Schematic presentation of the structures of the WT RMCK
(PDB ID 2CRK) and the three CTD fragments C101, C113, and C125.
The residues at the truncated sites were labeled.Aldrich (St. Louis, MO). Dithiothreitol was a BIOMOL (Plymouth
Meeting, PA) product. All other chemicals were local products of analytical
grade. The linker peptide L-f (GGFKPTDKHKTDLNHENLKGGDDLD
PHY, residues 98–125), L-n (GGFKPTDKHKTDLNH, residues 98–112),
and L-c (ENLKGGDDLDPHY, residues 113–125) were synthesized and
verified by mass spectrometry.Protein expression and purification
The gene of the wild-type (WT) RMCK and the pET-21b expression vector
were the same as those described elsewhere (23). Five isolated domains:
N100 (residues 1–100), N112 (residues 1–112), C101 (residues 101–
381), C113 (residues 113–381), and C125 (residues 125–381) and six
mutants were constructed using the primers listed in Table S1 in the Sup-
porting Material. Details regarding protein expression and purification
were the same as those described previously (23). All protein samples
were in 10 mM Tris-HCl buffer, pH 8.0. The protein concentration was
determined according to the Bradford method by using bovine serum
albumin as a standard (24). The final concentration of the dimeric WT
protein was 3 mM, whereas those of the monomeric mutants were 6 mM
for all experiments unless otherwise indicated.Activity assay
The activity of the WT and mutated enzymes was determined according
to the pH-colorimetry method (25) at 25C. The activity of the cell lysates
was determined using a coupled enzyme reaction system as described
previously (26).Spectroscopy
Intrinsic fluorescence spectra were recorded on an F2500 spectrophotom-
eter (Hitachi, Tokyo, Japan) using a 0.2 ml cuvette with an excitation wave-
length of 295 nm. Parameter A, which is the characteristic of the shape and
position of the fluorescence spectrum, was calculated by dividing the
intensity at 320 nm by that at 365 nm (I320/I365) (27). Far-ultraviolet
(UV) circular dichroism (CD) spectra were measured on a Jasco-715 spec-
trophotometer (Jasco, Tokyo, Japan) using a cell with a path length of
0.1 cm. All resultant spectra were obtained by the subtraction of the spectra
of the buffer.Protein thermal unfolding and aggregation
The thermal unfolding of the proteins was investigated by incubating the
samples at the given temperature for 2 min, and the data were recorded
every 2C. The time-course aggregation was monitored by measuring
A400 with a 4300 pro UV/Visible spectrophotometer (Ultraspec, Amersham
Biosciences, Piscataway, NJ) using a 0.2 ml cuvette at 50 or 46C. The
aggregation kinetics was analyzed using a first-order reaction as proposed
previously (28), and the data fitting were performed by nonlinear regression
analysis using the following equation:
A ¼ Alim

1 exp kaggðt  t0Þ

; (1)
where Alim is the A400 value at the infinite time, t is the time of incubation at
a given temperature, and kagg is the rate constant of the first-order reaction.
The thermal transition curves from CD were analyzed by a two-state
thermal unfolding model, and the following equation was used for the




þ ðyu þ muTÞeðDHm=RTÞðTTmÞ=Tm
1þ eðDHm=RTÞðTTmÞ=Tm ; (2)Biophysical Journal 103(3) 558–566
560 Chen et al.where y is the mean residue molar ellipticity at 222 nm or parameter A of
Trp fluorescence, T is the temperature, Tm is the temperature where half
unfolding is achieved, R is the Boltzmann constant and DHm is the enthalpy
of unfolding of Tm. The pre- and posttransitional baselines were defined
by (yf þ mfT) and (yu þ muT). For the transition curve of WT RMCK
from CD spectroscopy, the three-state process was analyzed by the sum
of two sequential two-state processes because a stable intermediate could
be observed.Molecular dynamics (MD) simulation
CK structures were simulated by atomistic molecular dynamics (MD)
simulation, using the CHARMM22 force field in the program NAMD2.7
(29). The x-ray crystal structure of RMCK (PDB code 2CRK) was adopted
as the starting structure. By removing the NTD at residues 101, 113, or 125,
respectively, three models of the RMCK CTD (C101, C113, and C125)
were built with decreasing length of the linker. Another model (C113 þ
L-n) was built by breaking the peptide bond between residues 112 and
113 of C101 to further analyze the protection role of the linker. Each protein
was explicitly solvated by TIP3 water molecules, and 0.01 mol/L Naþ and
Cl ions were placed into the water box to neutralize the system. Each
model was equilibrated for 11 ns and simulated for 10 ns at high tempera-
ture (400 K) and room temperature (300 K), respectively. All simulations
were conducted under constant temperature (300 K/400 K) and pressure
(1 atm), controlled by Langevin dynamics and Langevin piston, respec-
tively. To quantify the aggregation tendency of each residue, spatial
aggregation propensity (SAP) (30) value was calculated for each system.
This parameter was scaled between 0.5 and þ0.5, to evaluate the hydro-
phobicity of the microenvironment around a specific residue in a given
protein structure. A large positive SAP score typically indicates a greater
aggregation tendency. The SAP score for all residues were calculated
by averaging over all structural snapshots in the 10 ns productive simula-
tions. The aggregation propensity for each residue was also calculated by
the Zyggregator method (31) using the online computational algorithm
(http://www-vendruscolo.ch.cam.ac.uk/zyggregator_test.php).FIGURE 1 Structural properties of the WT RMCK and the CTD frag-
ments C101 and C113 evaluated by far-UV CD (A) and Trp fluorescence
spectroscopy (B). The spectra of the guanidine hydrochloride-denatured
state are also presented as open symbols.RESULTS
The linker is vital to CK assembly, but not to
domain structure
To evaluate the role of the linker in domain folding and
structure, five fragments of RMCK (N100, N112, C101,
C113, and C125) were overexpressed in E. coli. The five
domain fragments showed quite different behavior: N100
and N112 mainly existed in the supernatants, C101 and
C113 were in both the supernatants and precipitations,
whereas C125 mainly existed in the precipitant (Fig. S1).
However, the yields of N100 and N112 were very low and
the purity was unsatisfactory for structural analysis via spec-
troscopic experiments. Nonetheless, the CD spectrum of
N112 with ~90% purity indicated that the NTD fragments
were more likely to be well folded (Fig. S2). The corre-
sponding NTD and CTD fragments were mixed with an
equal molar ratio, equilibrated for 24 h at 25C, and then
the activity was measured. No CK activity was detectable
for the mixed solutions. The inability of the isolated NTD
and CTD to assemble to an active form was also verified
by the lack of CK activity in the soluble extracts of the
E. coli cells that coexpressed the N100/C101 or N112/Biophysical Journal 103(3) 558–566C113 fragments, which indicated that the intactness of the
linker was essential to RMCK assembly.
The CD spectra of the two CTD fragments exhibited
a typical shape of aþ b structure (Fig. 1). The mean residue
ellipticity at 222 nm was similar to the value of the WT
protein, indicating that secondary structures are well
preserved in both fragments. RMCK contains four Trp resi-
dues, and all of them are located in the CTD. The emission
maximum wavelengths (Emax) of the Trp fluorescence were
red-shifted from 334 to 337 nm by mutations, suggesting
that the Trp residues in C101 and C113 were more exposed
to solvent when compared to the WT protein. Thus, the
removal of the NTD did not significantly affect the regular
secondary structure contents, but resulted in a relative loose
tertiary structure of the CTD.The linker does not affect the thermal unfolding
but protects CTD against aggregation
Consistent with the previous studies (10,21), the thermal
unfolding of the WT RMCK was dominated by an irrevers-
ible two-state process (Fig. 2), and the midpoint of the main
thermal transition (Tm) was around 63
C (Table S2). A
minor transition at around the body temperature could
also be identified from the CD spectroscopy. The large
discrepancy between the Tm values obtained from the CD
FIGURE 2 Thermal transition curves of the WT RMCK, C101 and C113
by the mean residue molar ellipticity at 222 nm (A) and I320/I365 of the Trp
fluorescence spectra (B). The transition curves were fitted by Eq. 2, and the
thermodynamic parameters are listed in Table S2. For the transition curve of
WT RMCK from CD spectroscopy, both two-state and three-state models
were applied for fitting. The three-state fitting was performed by regarding
the transition as the sum of two sequential two-state processes because
a stable intermediate could be observed.
FIGURE 3 Thermal aggregation of the WT and mutated RMCKs. The
aggregation kinetics were measured by turbidity at 50C. The protein stock
solutions were mixed with the preheated buffers, and then the absorbance at
400 nm was recorded every 1 s.
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thermal unfolding of the WT RMCK involves noncoopera-
tive events, which coincides with the previous observation
(21). The minor transition in the WT protein thermal unfold-
ing was invisible for the two CTD fragments, revealing that
this transition correlated to the structural changes of the
NTD or modification of the domain/subunit interactions.
Nonetheless, the similar transition curves of two CTD frag-
ments indicated that the existence of the intact or truncated
linker did not significantly affect the thermal transitions of
the CTD.
A close inspection of the overexpression of the three
CTD fragments in the E. coli cells (Fig. S1) indicated that
the longer was the linker in the CTD fragments, the higher
content of soluble fractions. Turbidity measurements were
carried out to investigate the time-course aggregation of
the WT and truncated proteins at 50C (Fig. 3). Only minor
aggregation could be characterized by A400 for the WT
protein and C101, whereas C113 aggregated seriously and
quickly. The transmission electron microscopy images indi-
cated that the WT protein did not aggregate, C101 formed
small aggregates, whereas C113 was converted to large
amorphous aggregates after 10 min incubation at 50C
(Fig. S3). Aggregation studies were also conducted for thetwo isolated NTDs (with purity around 90%) with or
without the segment from residues K101 to H112. Neither
N100 nor N112 aggregated at 46C, which coincided with
the previous result that the CTD is responsible for RMCK
aggregation (21). When fitted by Eq. 1, the kagg value of
C101 was similar to the WT RMCK, whereas that of
C113 was ~14-fold larger than that of the WT protein (Table
S2). These results suggested that the intactness of the linker
significantly affected the thermal aggregation of the isolated
CTD, although contributed little to the thermal unfolding
transition.
The results in Fig. 3 suggested that the intact linker
behaved as a chaperone-like effect on CTD thermal aggre-
gation. To further verify this proposal, the intact linker
(L-f) and the truncated linker (L-n and L-c) peptides
were synthesized and provided additionally in the thermal
aggregation assay (Fig. 4). L-f could successfully protect
both C113 and C101 in a concentration-dependent manner,
and the aggregation could be fully suppressed with the
addition of >300 mM L-f. The truncated linkers L-n and
L-c also had the properties of preventing C113 and C101
aggregation, although the efficiency is much weaker than
that of L-f. It is worth noting that L-c was more efficient
than L-n, indicating that residues 113–125 was the major
contributor of the chaperone-like effect of the linker.
A quantitative evaluation was achieved by fitting the
aggregation kinetics using the first-order kinetics (Fig. 4,
D and F). The lag time, which reflected the conforma-
tional change before aggregation, was not significantly
affected by the addition of the linker peptide. The amounts
of aggregation monitored by Alim was slightly suppressed
by L-n and L-c, but was dramatically suppressed by L-f
in a saturation manner. All three peptides could success-
fully slow down the aggregation rate of C113. TheseBiophysical Journal 103(3) 558–566
FIGURE 4 Effect of the synthetic linker peptide on the thermal aggregation of C113 and C101. (A) Effect of L-f on C113 aggregation. (B) Effect of L-f on
C101 aggregation. (C) Effect of L-n and L-c on C113 and C101 aggregation. The experimental data were fitted by Eq. 1. The peptide concentration depen-
dence of the kinetic parameters of C113 aggregation is presented inD–F. The data of C101 were not fitted due to the failure of reaching the equilibriumwithin
the experimental time. Time-course aggregation at 46C was measured by turbidity. L-f, L-n, and L-c are the synthetic peptides with sequence corresponding
to the fragments 98–125, 98–112, and 113–125 in the WT RMCK, respectively.
562 Chen et al.observations suggested that the linker peptides did not
interfere with the conformational transition of C113 before
aggregation, but inhibit aggregation by blocking the adhe-
sion rate of the molecules.Role of the linker in CTD stability by MD
simulations and mutational analysis
To identify how the linker worked out as an IMC, we per-
formed MD simulations for C101, C113, and C125
(Fig. 5). The average SAP values ranging from residues
125 to 381 were 0.0462, 0.0465, and 0.420 at 300 K
and 0.0458, 0.0402, and 0.0410 at 400 K for C101,
C113, and C125, respectively. The largest SAP (Fig. 5)
and Zyggregator (Fig. S5) of C125 at room temperature
indicated it had the strongest aggregation propensity.
Meanwhile, the low SAP and Zyggregator scores of the
linker indicated that the linker was aggregation-resistant.
The key residues responsible for CTD aggregation were
characterized by comparing the SAP scores based on the
dissimilar properties of the three proteins. Three hydro-
phobic residues, Phe-250, Val-255, and Val-347, were
therefore identified. As shown in Table S3, in the presenceBiophysical Journal 103(3) 558–566of the full linker (C101), neither Phe-250 nor Val-347
exhibit significantly different SAP scores after temperature
rising (from 300 to 400 K). However, the significance ap-
peared when the linker was partially removed (in C113).
In other words, Phe-250 and Val-347 are significantly
more aggregation prone in the lack of the protection from
the integral linker. Notably, the significance of Val-255
also increases after the partial removal of the linker, as sug-
gested by the p-values of C101 and C113. Furthermore, in
the simulation system (C113 þ L-n) where the peptide
bond between residues 112 and 113 was cleaved in C101
and L-n was retained, these three residues were still aggre-
gation prone (with positive SAP scores: 0.071, 0.19, and
0.105), consistent with the previous conclusion that the L-
n was not the main contributor for the protection effect of
the linker (Fig. 4). Meanwhile, the linker residue Leu-115
was found to become more exposed to solvent when the
linker is progressively truncated: its SAP scores at 300
and 400 K grew from 0.002 and 0.01 in C101 to 0.09
and 0.17 in C113; simultaneously its SAP score in
C113 þ L-n (0.11) was positive and close to that in C113
at high temperatures. Consistently, our previous research
has shown that the mutation of Leu-115 dramatically
FIGURE 5 Role of the linker in CTD stability by MD simulations. (A–C)
SAP scores of the truncated forms C101, C113, and C125 at 300 K (solid
black lines) and 400 K (red dotted lines). The SAP score evaluates the
surface hydrophobicity of a residue based on three-dimensional structures.
Usually a residue with a high SAP score is highly prone to aggregation
because it creates a hydrophobic locus on the protein surface. (D and E)
The difference profiles of SAP scores at 300 and 400 K obtained by sub-
tracting the scores of C113 (solid lines) and C125 (dotted lines) by those
of C101. The residues responsible for CTD aggregation were characterized
based on the following two criteria: i), a low SAP score in C101 and C113
but a high score in C125 at 300 K; ii), a high SAP score in C113 and C125
but a low score in C101 at 400 K.
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(10).
The impact of Phe-250, Val-255, and Val-347 on CTD
aggregation was further investigated by mutational analysis
(Fig. 6). When substituted the three hydrophobic residues by
the polar residue Ser, the thermal aggregation of C113 was
suppressed, and the effect of Phe-250-Ser was the most
significant with a dramatic decrease of the aggregation
rate and amounts of aggregation. To speculate out whether
these three residues interacted with the linker, the aggrega-
tion behavior of the C101 and WT RMCK mutants werealso studied. For both C101 and RMCK, all of the three
mutations enhanced protein thermal aggregation. As for
C101, the impairing of Phe-250-Ser was the most serious,
followed by Val-347-Ser and Val-255-Ser. The opposing
effects of these mutations between C101 and C113
confirmed that these three residues were the adhesion sites
of aggregation protected by the intact linker. However, the
promoting effect of Val-347-Ser was the most significant
for the WT RMCK, followed by Phe-250-Ser and Val-
255-Ser. The kinetic parameter analysis indicated that the
mutants Val-347-Ser and Phe-250-Ser of RMCK had similar
aggregation rates, but different Alim values. Further analysis
of the thermal denaturation transition of RMCK and the
mutants indicated that Phe-250-Ser and Val-255-Ser had
the same Tm values (545 1
C) as the WT RMCK, whereas
that of Val-347-Ser was ~3C lower (Fig. 6 G). This sug-
gested that the former two mutations did not interfere with
the thermal transition, whereas Val-347-Ser slightly
decreased the thermal stability of RMCK. Nonetheless,
these results indicated that Phe-250 and Val-347 were two
crucial residues in mediating the chaperone-like effect of
the linker, whereas the role of Val-255 was moderate.DISCUSSION
Implications to CK folding mechanism
CK, a multimeric two-domain protein, has been proposed
to fold via a hierarchy process involving several intermedi-
ates (32,33). The folding of CTD is thought to be indepen-
dent and to happen before the folding of the NTD (34).
Mutational analysis indicated that the modifications of
intra- or interdomain interactions affect both the equilibrium
and kinetic folding pathways of CK (16,23,35). Several
reports have studied the structure and folding of isolated
segments or proteolytic products of CK, and have suggested
that the stability of NTD relies on domain interactions
(34,36,37). However, most of the previous work separated
the two domains within the CTD instead of the linker
region. In this research, we found that both the NTD and
CTD could fold to a well-structured state, which strongly
suggested that the domain and subunit interactions were
crucial to CK assembly into an active enzyme but not to
the autonomous folding of the domains. During the cotrans-
lational folding in vivo, the folded or partially folded NTD
and the linker protects the aggregation-prone CTD against
nonspecific intermolecular interactions and facilitates CK
folding and assembly. The opinion that the NTD enhances
the solubilization of the CTD has also been proposed by
studies of the three E. coli multidomain proteins (38).
The previous mutational analysis has indicated that the
correct positioning of the linker is important to RMCK
folding (10). However, mutations in the linker affect the
native structure of RMCK. The results herein clearly indi-
cated that the linker acts as an IMC (referred as IMC linker).Biophysical Journal 103(3) 558–566
FIGURE 6 Mutational analysis of the role of Phe-250, Val-255, and Val-347 in RMCK thermal unfolding and aggregation. (A–C) Thermal aggregation of
C113 (A), C101 (B), and RMCK (C) at 46C. (D–F) Comparison of the kinetic parameters of thermal aggregation. (G) Thermal unfolding transition curves of
the WT RMCK and the mutants. The raw data (symbols) were fitted by Eq. 2, and the fitted data are presented as solid lines.
SCHEME 2 Proposed open-and-close model of the action of the IMC
linker. The linker acts as a lid to protect the hydrophobic site against expo-
sure to solvent. At elevated temperatures, the lid (linker) is easily opened
with a large dissociation constant, and the protein is prone to aggregate
by the adhesion of the hydrophobic site. The addition of extrinsic lid
(synthetic linker peptide) can prevent the hydrophobic exposure, and thus
rescue the proteins from the aggregation pathway.
564 Chen et al.We found that the linker specifically protects the CTD
but not the NTD against aggregation, consistent with the
fact that the CTD is the adhesion sites of RMCK aggrega-
tion (21). The existence of the intact linker did not affect
the thermal unfolding pathway (Fig. 2) of the CTD,
implying that its function was mainly through influence
on the aggregation pathway. The action of the linker was
verified by mutational analysis of the key residues,
Phe-250, Val-255, and Val-347, characterized by MD simu-
lations. The substitution of these hydrophobic residues
by the polar residue Ser could successfully inhibit the
aggregation of CTD with the truncated linker, but acceler-
ated the thermal aggregation of both the WT enzyme and
CTD with the intact linker. This opposing effect of the
mutations strongly suggested that the existence of the
linker in the native protein actually acted as an IMC to
prevent the protein against aggregation when subject to
stresses. Structurally, the linker acts as a lid to protect the
hydrophobic side chains of Phe-250 and Val-347, but not
Val-255 against exposure to solvent (Fig. S6, Scheme 2).
This can explain why the effect of mutations at Phe-250
and Val-347 were much more pronounced than that of
Val-255. When the lid (linker) is easily opened with a large
dissociation constant at elevated temperatures, the protein
is prone to aggregate. Meanwhile, the addition of extrinsic
lid could successfully rescue the proteins from the aggrega-
tion pathway.Biophysical Journal 103(3) 558–566Proposed actions of IMC linkers in protein folding
and aggregation
Our current understanding of IMCs is mainly based on
extensive studies of preproproteins (6). Recently, the
Chaperone-Like Effect of the Linker of CK 565functional regions have also been characterized as IMCs in
several proteins (8–13), implying that IMCs might be much
more universal than previously expected (13). However, it is
seldom found that the linkers in multidomain proteins can
act as IMCs. One well-studied case is the linker, also called
C-peptide, in human proinsulin, which can act as an IMC
to facilitate the formation of disulfide bonds by correctly
positioning the N- and C-terminal fragments (39). Although
the in vitro folding of multidomain proteins usually
competes with aggregation and needs the help of molecular
chaperones or foldases, many others such as CK can refold
independently in vitro. The fact that at least some linkers
can behave as a chaperone-like activity may be important
to the understanding of how multidomain proteins fold
after translation in vivo and how they avoid off-pathway
aggregation during unfolding upon stresses or other physio-
logical processes. That is, besides the widely studied
chaperones and foldases, the cells may have evolved intra-
molecular mechanism such as IMCs to fight against the
unproductive aggregation pathway (6). The characterization
of potential IMCs, particular IMC linkers, may facilitate
the recombinant production of isolated domains because
there are no general guidelines for designing construction
coding for a single domain of a multidomain protein (40).
The distinct features of IMCs from intermolecular chap-
erones and foldases have been thoroughly discussed by
Ma et al. previously (13). In particular, they have proposed
that the uncleaved IMCs not only play a role in the folding
pathway, but also have their own physiological importance
in protein function. This is exactly the case for the linker
of RMCK, which is essential to the binding of RMCK to
the M-line (20). On the basis of those proposed by Ma
et al. (13) and the observations herein, the following features
are proposed for an IMC linker: i), the existence of the IMC
linker facilitates the folding of the protein by assisting the
correct positioning of adjacent domains/fragments, but
does not significantly affect the thermodynamics of protein
folding; ii), the IMC linker covalently linked to the protein
protects the aggregation-prone domain, mostly at the
C-terminal part of the IMC linker, against aggregation
during refolding and unfolding; iii), the disruption of the
IMC linker either by mutations or by deletions promotes
protein aggregation; iv), the IMC linker provided addition-
ally prevents protein aggregation in a concentration depen-
dent manner. The essential concentration of the linker
fragment to fully block the aggregation depends on the
dissociation constants of both the linker covalently linked
to the protein and provided non-covalently. Thus, the
behavior of the linker is not stoichiometric, but is between
the intermolecular chaperones/foldases and the non-specific
chemical chaperones.
The characterization of IMC linkers in proteins is impor-
tant not only to the understanding of protein folding but
also to protein aggregation. In particular, the results of the
two truncated CTD forms mimicked the different propertiesof various proteolytic products. The relative flexible linker
region is prone to be cleaved by proteases. Actually,
RMCK was very sensitive to proteolysis by trypsin or
protease K (Fig. S4). The dissimilar behaviors of C101
and C113 suggested that the intact but not truncated IMC
is crucial to the chaperone-like effect on the aggregation
of protein segments. The disruption of IMC linkers might
be vital to the onset of some aggregation diseases because
the deposition of the proteolytic fragments is frequently
observed in the pathology of many diseases (41). Although
it is unclear yet how much proteolysis contributes to the
diseases accompanied with CK inactivation or deficiency,
it is clear that CK aggregation is important to the onset of
some diseases such as acute myocardial infarction caused
by the inherited D54G mutation (16) and Alzheimer’s
disease (42). CK is also found to form aggresomes in cells
subjected to nitrogen-based oxidative stress (19).
The fact that the disruption of IMCs will greatly accel-
erate the nonnative aggregation of the corresponding pro-
teolytic species also provides the possibility of the
involvement of uncleaved IMCs in the onset of protein
aggregation diseases. This opinion is well documented in
preproproteins. For example, mutations in the IMC prodo-
main have been characterized in several diseases, which
are named as protein-memory diseases (6,43). The C-
terminus of a-synuclein is characterized to be an IMC and
its removal will accelerate a-synuclein fibrilization, which
is suggested to be a critical factor in several neurodegener-
ative diseases (44). The IMC function of BRICHOS, a novel
domain located in the propeptide region of several proteins,
is proposed to be related to dementia, respiratory distress,
and cancer (45). However, the relationship between the un-
cleaved IMCs and aggregation in diseases remains elusive
due to the limited reports of IMCs in the other proteins
apart from preproproteins. The observation that IMC linker
added additionally could prevent protein aggregation also
provides a valuable strategy to fight against protein aggrega-
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